SORENSEN MEL (President and CEO) sold 20.2% of their position (67.02K shares) of GALERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2024ACC: 0000950170-24-099168
DirectorOfficer· President and CEO
Since Nov 2019
-67.02K
Net shares
Net seller
$4.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
67.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−67.02K
Price / share
$0.07
Trade value
$4.83K
% of position
20.2%
8/16/2024
332.04K→265.03K
Total
Net shares
−67.02K
Net value
-$4.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2024 | S · Sale | −67.02K | $0.07 | $4.83K | 20.2% | 332.04K | 265.03K |
| Total | −67.02K | -$4.83K | ||||||
Derivative Transactions0
No derivative transactions reported